TY  - JOUR
AB  - Background
Bufei Yishen formula (BYF), a traditional Chinese medicine (TCM), is an effective therapeutic strategy for patients with chronic obstructive pulmonary disease (COPD).

Purpose
To evaluate the efficacy of BYF and investigate its therapeutic mechanisms.

Methods
A total of 134 patients completed the study: 68 patients treated by BYF combined with conventional Western medicine in the trial group; and 66 patients treated using conventional Western medicine in the control group. The efficacy of BYF was evaluated by a subgroup analysis of data obtained from a four-center, open-label, randomized controlled trial of comprehensive TCM interventions. A rat model of COPD was treated with the key active molecules (KAM) of BYF for 8 weeks. An in vitro model of COPD was also treated with KAM.

Results
Patients treated with BYF had reduced frequency of acute exacerbation of COPD (p < 0.001) and duration (p?=?0.028), dyspnea scale (p?=?0.007), 6-min walking distance (p?=?0.048). There were no differences observed in forced vital capacity in one second (FVC), forced expiratory volume in one second (FEV1), and FEV1 percentage of the predicted value (FEV1%). The five KAM of BYF (KAM-BYF) improved lung function, including tidal volume, minute ventilation, peak expiratory flow, FVC, FEV0.1, and FEV0.3, and pathological changes in COPD rats. Treatment with KAM-BYF markedly decreased the levels of interleukin 6 (IL6), tumor necrosis factor-? (TNF-?), matrix metalloproteinase 9 (MMP9), and MMP12 in serum and bronchial alveolar lavage fluid. In airway epithelial cells, KAM-BYF decreased the levels of TNF-?-induced IL8 and IL6. Finally, we discovered that the anti-inflammatory effects of KAM-BYF in COPD rats and BEAS-2Bs were mediated through inhibition of nuclear factor-kappaB (NF-?B) p65, c-Jun NH2-terminal kinase (JNK), and p38 mitogen-activated protein kinase signaling.

Conclusions
BYF exerts beneficial effects in patients with COPD via inhibition of inflammation.
AU  - Li, J
AU  - Xie, Y
AU  - Zhao, P
AU  - Qin, Y
AU  - Oliver, BG
AU  - Tian, Y
AU  - Li, S
AU  - Wang, M
AU  - Liu, X
DA  - 2021/01/20
DO  - 10.1016/j.phymed.2021.153475
JO  - Phytomedicine
PB  - Elsevier
PY  - 2021/01/20
SP  - 153475
TI  - A chinese herbal formula ameliorates COPD by inhibiting the inflammatory response via downregulation of p65, JNK, and p38
VL  - 83
Y1  - 2021/01/20
Y2  - 2026/05/22
ER  -